We describe a technique of microinjecting the aminoglycoside, gentamicin, into 2 days post-fetilization (dpf) zebrafish larvae to induce acute kidney injury (AKI). We also describe a method for whole mount immunohistochemistry, plastic embedding and sectioning of zebrafish larvae to visualize the AKI mediated damage.
Part of the following protocol is based on published methods reported by (Hentschel et al. 2005) and (Weinstein et al. 1995) with slight modifications.
Part 1: Microinjections
Set up in advance for microinjection
Microinjection
The following steps are performed under a dissecting microscope
Part 2: Fixation and immunofluorescence with Na+/K+ ATPase antibody (α-6F)
Part 3: Plastic embedding with JB-4
Part 4: Sectioning
Part 5: Representative Results
When performed correctly, injected fish appear like in figure 1, with little fluorescent dextran (in this case Lucifer Yellow) visible in the heart and in the circulatory system. If the injection is too deep, injected material can be seen concentrated in the yolk sac, or the heart can be punctured causing excessive bleeding. If the holding pipette is made correctly, the fish won't roll or move when injected, and this will allow a more accurate injection. Also, it's important to make sure not to have any air bubbles in the MMP, which would slow the response time and decrease the precision of the system. Generally, as a consequence of gentamicin nephrotoxicity, 80% of the injected fish develop pericardial edema (Fig. 2). We use a phenotype based classification system, in which fish with moderate edema show evident pericardial edema but no others observable phenotypes, whereas severely edematous fish show pericardial and trunk edema, with slight to moderate axis curvature. Using a renal tubule antibody against Na+/K+ ATPase (α-6F) we can visualize the damaged tubules in transverse sections, with an evident loss of cell polarity and tubular disruption in damaged tubules as compared to controls (Fig. 3). This pattern is consistent through multiple transverse sections. In order to obtain perfect transverse sections of the renal tubules is important to position the fish correctly during the embedding. When comparing sections, pectoral fins and proximal convoluted tubules are used as anatomical markers.
Figure 1. Nephrotoxin microinjection. (A) Successful injection of a 10kDa dextran conjugated to lucifer yellow, with faint expression in the common cardinal vein, white arrow. (B) Incorrect injection, resulting in a deposit of 10kDa dextran conjugated to lucifer yellow that does not dissipate into the circulatory system, red arrow.
Figure 2. Gentamicin-mediated edema. (A) Control injected larval zebrafish. Gentamicin injected larval zebrafish with (B) moderate or (C) severe edema. All larvae are at 4 dpf with anterior to the left and dorsal is up. Black arrows point to pericardial edema in B and C.
Figure 3. AKI immunohistochemistry. α-6F antibody staining for Na+/K+ ATPase 48 hours-post gentamicin injection (4 dpf larvae) in control (A,B) and gentamicin injected (C,D) larvae. A, C are at 20X magnification and of B and D are 3X digital magnifications of the right tubules in A and C. Note loss of basolateral polarity and tubule disruption, white arrow, in D as compared to B.
In this video article we demonstrated an intravenous microinjection technique for an AKI model, by creating gentamicin mediated proximal tubular damage in zebrafish larvae. This damage results in the formation of pericardial and/or gross edema, reflecting an inability to regulate water balance. We also described an immunohistochemistry experiment with an antibody that marks differentiated kidney tubules (Majumdar et al. 2000), showing loss of cell polarity and a disruption of the proximal tubule in damaged kidneys. Intravenous microinjections represent an efficient method for delivering a soluble substance into the bloodstream of zebrafish larvae. This technique is an excellent tool for the introduction of a variety of substances and with the aid of a fluorescent marker uniform injections can be repeated many times over allowing for consistent results.
The authors have nothing to disclose.
This work was funded by the US National Institutes of Health (NIH) grants R01DK069403 and P30DK079307.
Material Name | Tipo | Company | Catalogue Number | Comment |
---|---|---|---|---|
α6F mouse monoclonal | Developmental study Hbridoma Bank | |||
Block Holder EBH-2 | Polysciences, Inc. | 15899 | ||
Borosilicate Glass Capillaries | World Precision Instruments, INC | TW100-6 | ||
Capillary tubes R-6 Custom Glass Tubing | Drummond Scientific Company, Broomall PA | 9-000-3000 | ||
Catalyst Powder | Polysciences, Inc. | 02618 | ||
Cy3 | Jackson Immunoresearch Laboratories, Inc. | 155-165-003 | ||
Dextran 10k Lucifer yellow, lysine fixable | Molecular probes | D1825 | ||
DMSO | Sigma | D8418 | ||
Eyelash | Ted Pella | 113 | ||
Gentamicin sulfate | Sigma-Aldrich | G8648 | ||
Glass vials 4ml | Weathon | 225012 | ||
Iron plate | Nariscige | IP | ||
JB-4 Embedding Solution A | Polysciences Inc. | 0226A | ||
JB-4 Embedding Solution B | Polysciences, Inc. | 0226B | ||
Joystick micromanipulator | Narishige | MN 151 | ||
Magnetic stand | Narishige | MN-151 | ||
Manual microsyringe pump | World Precision Instruments, Inc | |||
Microinjection apparatus | World Precision Instruments, Inc. | PV820 | ||
Micromanipulator | World Precision Instruments, Inc. | M3301R | ||
Microtome | Thermo Electro Corporation | Shandon Finesse | ||
Mineral oil, light | Fisher Chemicals | 0121-1 | ||
Pipette puller | Kopf | 720 | ||
Plastic molding cup tray | Polysciences, Inc. | 16643A | ||
Razor blade | WVR Scientific | 55411-050 | ||
Slide warmer | Lab line | |||
Stage micrometer | Wards | 94 W 9910 | ||
Tilting base | World Precision Instruments, Inc. | TB 1 | ||
Tricaine powder | Sigma | A-5040 | ||
Tween 20 | Sigma | P7949 | ||
Microscope | Leica | S6F | Dissecting microscope | |
Microscope | Leica | M205FA | Fluorescent microscope |